Figure 2From: Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patientsOverall survival for all patients from time of SBRT. The median OS was 7.6 months. Six-month and 12-month OS rates were 65.4% and 34.6%, respectively.Back to article page